Rob Shaffer

Rob Shaffer

Company: Enable Therapeutics

Job title: Founder


Targeting Glycogen in Childhood Dementia with Expansion Potential to Larger Neurodegenerative Indications 1:03 pm

Childhood dementias such as Lafora Disease (LD) are fatal and fewer than 5% have effective treatments An antibody-enzyme fusion clears accumulated pathogenic glycogen in the brain of LD animal models, rescuing metabolism and glycosylation patterns Highlights a putative strategy for currently untreatable neurodegenerative diseases with demonstrated elevated glycogenRead more

day: Pre-Conference Discussion Day

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.